Related Experiment Video

Updated: Jun 12, 2026

Assessing Specificity of Anticancer Drugs In Vitro
09:39

Assessing Specificity of Anticancer Drugs In Vitro

Published on: March 23, 2016

Pharmacogenetic application in personalized cancer treatment

Hendy Kristyanto1, Ahmad R Utomo

  • 1Faculty of Medicine University of Indonesia, Jl. Salemba 6 Jakarta Pusat 10430, Indonesia. hendykris@gmail.com

Acta Medica Indonesiana
|June 2, 2010
PubMed

Insights

Pharmacogenetics uses genetic testing to predict drug response, helping avoid adverse reactions and personalize cancer treatments. This approach optimizes therapy selection and recurrence prediction, improving patient outcomes and reducing costs.

Area of Science:

  • Pharmacogenetics
  • Clinical Genetics
  • Cancer Therapeutics

Background:

  • Genetic variations significantly influence individual drug responses.
  • Pharmacogenetics offers applications in cancer treatment, including adverse drug reaction (ADR) avoidance, treatment selection, and recurrence prediction.
  • Specific gene variations (e.g., UGT1A1, DPYD) are linked to hypersensitivity to certain chemotherapy drugs.

Purpose of the Study:

  • To explore the multifaceted applications of pharmacogenetics in optimizing cancer treatment.
  • To highlight how genetic testing can predict drug efficacy and patient outcomes.
  • To demonstrate the potential of pharmacogenetics in personalizing cancer care.

Main Methods:

  • Review of existing studies on pharmacogenetic applications in oncology.
  • Analysis of genetic markers influencing drug response (e.g., UGT1A1, DPYD).
  • Evaluation of gene expression profiling for predicting cancer recurrence (e.g., 70-gene signature in breast cancer).

Main Results:

  • Genetic tests can predict hypersensitivity to drugs like Irinotecan and 5-Fluorouracil (5FU), enabling ADR avoidance.
  • Tumor genetic/epigenetic markers impact the efficacy of targeted and non-targeted cancer therapies (e.g., Cetuximab, temozolomide).
  • Gene expression profiling can identify patients who may not require chemotherapy, thus avoiding side effects.

Conclusions:

  • Pharmacogenetic testing is crucial for informed clinical decision-making in cancer treatment.
  • It enables personalized medicine by predicting treatment success and minimizing adverse events.
  • Implementing pharmacogenetics can lead to improved patient outcomes and cost savings in cancer care.

More Related Videos

Multi-Gene Single Nucleotide Polymorphism Detection in Gastric Cancer Based on Ion Semiconductor Sequencing Platform06:21

Multi-Gene Single Nucleotide Polymorphism Detection in Gastric Cancer Based on Ion Semiconductor Sequencing Platform

Published on: May 10, 2024

Related Concept Videos

Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Pharmacogenetics and Pharmacogenomics: Overview01:29

Pharmacogenetics and Pharmacogenomics: Overview

Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...